Early results show promise of CAR-T cell therapy for treating rare blood cancer
Eight of 11 patients (72.7%) treated in a early stage international clinical trial of a new drug for a rare form of blood cancer achieved complete remission, meaning there were no signs of cancer after treatment, a new study shows.
Enhanced imaging detects significantly more cancers in dense breasts compared to conventional mammograms
Adding enhanced imaging for breast cancer screening for women with dense breasts could triple the rate of early cancer detection among these women.
Data study showed brain cancer patients who took pain drug survived an average of 4 months longer
Image of glioblastoma cells – Credit UCSF Brain Tumor Center CANCER DIGEST – May 17, 2025 – Patients with the most common and lethal form...
Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer
Sequence of treatment matters in second-line and third-line therapy for a certain type of blood cancer
Permanent gene editing of T cell DNA shown to be safe in first clinical trial
New gene-editing therapy shows early success in fighting advanced GI cancers. Illustration provided by University of Minnesota
Engineered T cells targeting solid tumors show promising results in early patient trial
The IMA203 treatment uses T cells engineered to target the PRAME peptide, which is almost exclusively produced by solid tumors and not...
